By Catherine Frenette MD FAST AGAF
In collaboration with Consulting Editor, Dr. Norman Gitlin, Guest Editor Dr. Catherine Frenette has assembled expert authors to provide current updates on Hepatocellular Carcinoma (HCC). This issue asks important questions and provides answers and current thoughts on the staging and treatment of HCC. Clinical review articles are specifically dedicated to the following topics: The Changing Global Epidemiology of Hepatocellular Carcinoma; Prevention Strategies for HCC; Biomarkers or Biopsy for Diagnosis of HCC; Screening and Surveillance Strategies to Improve the Chance of Success; Imaging Diagnosis of HCC; Surgical Resection: Old dog–Any new tricks; Hepatocellular Carcinoma and Liver Transplant: How Will Organ Allocation Changes Affect the HCC Patient Within Transplant Criteria; Downstaging to Liver Transplant: Success Involves Choosing the Right Patient; Locoregional Therapies for Hepatocellular Carcinoma: What has Changed in the Past Ten Years; External Beam Radiotherapy: Is There a Place for This in HCC Treatment; Tyrosine Kinase Inhibitors and Hepatocellular Carcinoma; Immuno-oncology for Hepatocellular Carcinoma: The Present and the Future; Management of Side Effects of Systemic Therapies for HCC: Guide for the Hepatologist; and Why a Multi-disciplinary Tumor Board is Critical for Success with Hepatocellular Carcinoma. Readers will come away with the information they need to improve patient outcomes in the patient with HCC.

Hepatocellular Carcinoma (HCC) is the most common type of primary liver cancer. It is a highly aggressive and often fatal disease that affects millions of people worldwide. To understand and effectively manage HCC, it is crucial to stay updated with the latest research, treatment strategies, and diagnostic techniques. In the field of hepatology, one publication stands out as a comprehensive guide to all things HCC – The Journal of Hepatology Special Issue: Hepatocellular Carcinoma (HCC): Staging and Treatment.

Edited by renowned experts in the field, Dr. Catherine Frenette and Dr. Norman Gitlin, this special issue brings together a team of expert authors to provide up-to-date information on various aspects of HCC. Whether you are a hepatologist, gastroenterologist, oncologist, or any other healthcare professional involved in the management of HCC, this publication is an invaluable resource.

The special issue covers a wide range of topics related to HCC. It starts with an overview of the changing global epidemiology of HCC, highlighting the increasing burden of the disease. The issue then delves into prevention strategies for HCC, discussing the role of vaccinations, antiviral therapies, and lifestyle modifications in reducing the risk of developing HCC.

Diagnosing HCC can be challenging, and the special issue addresses this by exploring the use of biomarkers and biopsies for accurate diagnosis. It also provides insights into screening and surveillance strategies to improve early detection and increase the chances of successful treatment.

Imaging plays a crucial role in the diagnosis and staging of HCC, and the special issue delves into the various imaging techniques used, their limitations, and advancements in the field. Surgical resection and liver transplant are vital treatment options for HCC, and the publication discusses the latest developments in these areas.

Advancements in locoregional therapies, external beam radiotherapy, tyrosine kinase inhibitors, and immunotherapy are also extensively covered in the special issue. The authors provide a comprehensive review of the current evidence, efficacy, and future directions of these treatment modalities.

Managing the side effects of systemic therapies is crucial for improving patient outcomes, and the special issue offers a guide for hepatologists in this regard. Additionally, the importance of a multi-disciplinary tumor board for successful HCC management is emphasized.

In summary, The Journal of Hepatology Special Issue: Hepatocellular Carcinoma (HCC): Staging and Treatment is a must-have resource for any healthcare professional involved in the management of HCC. Through its comprehensive and up-to-date articles, the publication equips readers with the knowledge and tools necessary to improve patient outcomes in HCC.

If you are looking to stay at the forefront of HCC management, this special issue is a valuable addition to your professional library. Order your copy today and join the experts in shaping the future of HCC treatment.

Product Details

• Publisher: Elsevier (October 26, 2020)
• Language: English
• eBook Digital: 240 pages
• ISBN-10: 0323711405
• ISBN-13: 978-0323711401